NCT02069613

Brief Summary

The objective of the study is to determine the relative roles for various testing modalities in the diagnosis and prognosis of mild traumatic brain injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2014

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 24, 2014

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

November 8, 2017

Status Verified

November 1, 2017

Enrollment Period

3.4 years

First QC Date

February 18, 2014

Last Update Submit

November 6, 2017

Conditions

Keywords

Mild traumatic injury to extremity (for controls)mTBIconcussionMEGEEGBloodMRIDTIbiomarkers

Outcome Measures

Primary Outcomes (1)

  • Change in objective measures of brain function (MEG/EEG, blood biomarkers)

    For MEG/EEG, resting state analyses of brain function will be conducted to include frequency band analyses localizing, for example, delta slow wave activity, and establishing functional connectivity scores at three time points post injury (day 1, day 14, day 30). For blood biomarkers, serum levels in approximately ten biomarkers will be measured to determine amount in each and if changes occur at three time points post-injury.

    Day 1, day 14, and day 30 post-injury

Secondary Outcomes (1)

  • Change in anatomical measures of brain function (DTI, SWI)

    Day 1, day 14, and day 30 post-injury

Study Arms (2)

Mild traumatic brain injury (mTBI)

Patients admitted to Huntington Memorial Hospital (HMH), Pasadena CA, Emergency Department (ED) diagnosed with mTBI by history (alteration of consciousness, post-traumatic amnesia, loss of consciousness) and normal brain computed tomography (CT).

Control

Patients admitted to HMH ED for minor extremity trauma (sprains) and no evidence of mTBI

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Study participants (control, mTBI) will be referred by the Huntington Hospital Emergency Department staff. ED staff will determine the eligibility criteria. If consent is achieved, testing will occur at pre-determined times: 1 day, 14 days, and 30 days post-injury.

You may qualify if:

  • \. Civilian (non-military) presenting to HMH ED.

You may not qualify if:

  • Prior history of diagnosed TBI.
  • Other significant non-head injury/trauma or open wound.
  • Other significant medical co-morbidities, such as heart disease or cancer.
  • Self-reported current use or substances contributing to ED visit (e.g. illicit drugs, medications, alcohol abuse).
  • Currently diagnosed psychological condition (e.g. depression, PTSD).
  • Medications for psychological or neurological disorder.
  • Any implanted metal, such as medical device or braces on teeth.
  • Injury to the back or other injury that will make it difficult for the participant to tolerate tests.
  • Injury to dominant arm that would cause difficulty using computer or responding to stimuli during functional imaging.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Huntington Medical Research Institutes

Pasadena, California, 91101, United States

Location

HMRI

Pasadena, California, 91105, United States

Location

Molecular Neurology Program

Pasadena, California, 91105, United States

Location

Related Publications (6)

  • Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med. 2008 Jan 31;358(5):453-63. doi: 10.1056/NEJMoa072972. Epub 2008 Jan 30.

    PMID: 18234750BACKGROUND
  • Bigler ED. Neuropsychology and clinical neuroscience of persistent post-concussive syndrome. J Int Neuropsychol Soc. 2008 Jan;14(1):1-22. doi: 10.1017/S135561770808017X.

    PMID: 18078527BACKGROUND
  • Lewine JD, Davis JT, Bigler ED, Thoma R, Hill D, Funke M, Sloan JH, Hall S, Orrison WW. Objective documentation of traumatic brain injury subsequent to mild head trauma: multimodal brain imaging with MEG, SPECT, and MRI. J Head Trauma Rehabil. 2007 May-Jun;22(3):141-55. doi: 10.1097/01.HTR.0000271115.29954.27.

    PMID: 17510590BACKGROUND
  • Huang MX, Theilmann RJ, Robb A, Angeles A, Nichols S, Drake A, D'Andrea J, Levy M, Holland M, Song T, Ge S, Hwang E, Yoo K, Cui L, Baker DG, Trauner D, Coimbra R, Lee RR. Integrated imaging approach with MEG and DTI to detect mild traumatic brain injury in military and civilian patients. J Neurotrauma. 2009 Aug;26(8):1213-26. doi: 10.1089/neu.2008.0672.

    PMID: 19385722BACKGROUND
  • Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma. 2004 Nov;57(5):1006-12. doi: 10.1097/01.ta.0000108998.48026.c3.

    PMID: 15580024BACKGROUND
  • Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004 Apr 27;62(8):1303-10. doi: 10.1212/01.wnl.0000120550.00643.dc.

    PMID: 15111666BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood will be retained for future analysis.

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Michael G Harrington, MB

    Huntington Medical Research Institutes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

February 18, 2014

First Posted

February 24, 2014

Study Start

March 1, 2014

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

November 8, 2017

Record last verified: 2017-11

Locations